PIK3CA and nasopharyngeal carcinoma: Somatic mutations enriched in the PI3K and MAPK pathways, such as Harvey-RAS (HRAS) and neuroblastoma-RAS (NRAS), are considered key factors driving NPC recurrence [11,14].